Aberrant pre-mRNA processing in cancer
Journal of Experimental Medicine · 2024
DOI: 10.1084/jem.20230891 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Experimental Medicine, 2024. Verfasst von Jeetayu Biswas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Hauptthemen laut MEDLINE: RNA Precursors, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, Edward P. Evans Foundation.
Abstract (Originalsprache)
Dysregulation of the flow of information from genomic DNA to RNA to protein occurs within all cancer types. In this review, we described the current state of understanding of how RNA processing is dysregulated in cancer with a focus on mutations in the RNA splicing factor machinery that are highly prevalent in hematologic malignancies. We discuss the downstream effects of these mutations highlighting both individual genes as well as common pathways that they perturb. We highlight examples of how alterations in RNA processing have been harnessed for therapeutic intent as well as to promote the selective toxicity of cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
ORCID-Profile: Jeetayu Biswas, Leora Boussi, Eytan Stein, Omar Abdel-Wahab
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- Edward P. Evans Foundation
- Leukemia & Lymphoma Society
- NIH HHS
- National Institutes of Health
- National Cancer Institute
- National Heart, Lung, and Blood Institute
Zitieren
APA
Biswas, J., Boussi, L., Stein, E., & Abdel-Wahab, O. (2024). Aberrant pre-mRNA processing in cancer. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20230891
Vancouver
Biswas J, Boussi L, Stein E, Abdel-Wahab O. Aberrant pre-mRNA processing in cancer. Journal of Experimental Medicine. 2024. doi:10.1084/jem.20230891
BibTeX
@article{Biswas2024,
author = {Biswas, Jeetayu and Boussi, Leora and Stein, Eytan and Abdel-Wahab, Omar},
title = {Aberrant pre-mRNA processing in cancer},
journal = {Journal of Experimental Medicine},
year = {2024},
doi = {10.1084/jem.20230891}
}
EUVIMED